ATE241611T1 - Heterozyclische verbindungen als angiogenese inhibitoren - Google Patents

Heterozyclische verbindungen als angiogenese inhibitoren

Info

Publication number
ATE241611T1
ATE241611T1 AT00949831T AT00949831T ATE241611T1 AT E241611 T1 ATE241611 T1 AT E241611T1 AT 00949831 T AT00949831 T AT 00949831T AT 00949831 T AT00949831 T AT 00949831T AT E241611 T1 ATE241611 T1 AT E241611T1
Authority
AT
Austria
Prior art keywords
heterocyclic compounds
angiogenesis inhibitors
angiogenesis
inhibitors
heterocyclic
Prior art date
Application number
AT00949831T
Other languages
English (en)
Inventor
Nandor Makk
Gabor Ambrus
Aniko Tegdes
Andras Jeney
Ferenc Timar
Original Assignee
Gyogyszerkutato Intezet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyogyszerkutato Intezet filed Critical Gyogyszerkutato Intezet
Application granted granted Critical
Publication of ATE241611T1 publication Critical patent/ATE241611T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT00949831T 1999-08-02 2000-08-02 Heterozyclische verbindungen als angiogenese inhibitoren ATE241611T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902628A HUP9902628A3 (en) 1999-08-02 1999-08-02 Angiogenesis inhibiting borrelidin derivatives, their use and pharmaceutical compositions containing them
PCT/HU2000/000088 WO2001009113A2 (en) 1999-08-02 2000-08-02 Heterocyclic compounds inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
ATE241611T1 true ATE241611T1 (de) 2003-06-15

Family

ID=89998954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949831T ATE241611T1 (de) 1999-08-02 2000-08-02 Heterozyclische verbindungen als angiogenese inhibitoren

Country Status (32)

Country Link
US (1) US6815465B1 (de)
EP (1) EP1206462B1 (de)
JP (1) JP2003506366A (de)
KR (1) KR20020068495A (de)
CN (1) CN1243746C (de)
AP (1) AP1383A (de)
AT (1) ATE241611T1 (de)
AU (1) AU772206B2 (de)
BG (1) BG106373A (de)
BR (1) BR0012968A (de)
CA (1) CA2378176A1 (de)
CZ (1) CZ2002405A3 (de)
DE (1) DE60003045T2 (de)
DK (1) DK1206462T3 (de)
ES (1) ES2200900T3 (de)
HK (1) HK1048995B (de)
HR (1) HRP20020103B1 (de)
HU (1) HUP9902628A3 (de)
IL (1) IL147904A (de)
IS (1) IS2137B (de)
MX (1) MXPA02001117A (de)
NO (1) NO20020485L (de)
NZ (1) NZ517422A (de)
OA (1) OA12004A (de)
PL (1) PL354281A1 (de)
PT (1) PT1206462E (de)
RU (1) RU2247723C2 (de)
SK (1) SK1822002A3 (de)
UA (1) UA74341C2 (de)
WO (1) WO2001009113A2 (de)
YU (1) YU7302A (de)
ZA (1) ZA200200838B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
GB0230217D0 (en) * 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
US8440217B1 (en) 2005-06-15 2013-05-14 Mawaheb M. EL-Naggar Method and system with contact lens product for treating and preventing adverse eye conditions
GB0609981D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
GB0713563D0 (en) * 2007-07-13 2007-08-22 Biotica Tech Ltd Methods of screening for anti-angiogenic compounds
CN101835377B (zh) * 2007-08-27 2014-12-10 巴斯夫欧洲公司 用于防治无脊椎动物害虫的吡唑化合物
DE102008014077A1 (de) 2008-03-13 2009-09-17 Discovery Partner International Gmbh Borrelidin-Derivate
WO2009141786A2 (en) * 2008-05-21 2009-11-26 Piramal Life Sciences Limited Anti-inflammatory compounds
ES2720781T3 (es) 2014-12-15 2019-07-24 Borealis Ag Uso de una composición de polipropileno

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2099334C1 (ru) * 1986-06-06 1997-12-20 Американ Цианамид Компани Макролидные соединения, композиция, обладающая антибиотической активностью, ветеринарная композиция, инсектоакарицидонематоцидная композиция и способ уничтожения насекомых и/или клещей, нематод
JPH08173176A (ja) 1994-12-22 1996-07-09 Mercian Corp 血管新生阻害剤
JP3786461B2 (ja) 1996-02-22 2006-06-14 メルシャン株式会社 新生理活性物質

Also Published As

Publication number Publication date
IS6258A (is) 2002-02-01
WO2001009113A2 (en) 2001-02-08
HK1048995A1 (en) 2003-04-25
YU7302A (sh) 2004-09-03
NO20020485D0 (no) 2002-01-30
ZA200200838B (en) 2003-08-27
IL147904A (en) 2005-09-25
HU9902628D0 (en) 1999-10-28
WO2001009113A3 (en) 2001-06-14
HUP9902628A2 (hu) 2001-05-28
PL354281A1 (en) 2003-12-29
KR20020068495A (ko) 2002-08-27
MXPA02001117A (es) 2003-08-20
RU2247723C2 (ru) 2005-03-10
HRP20020103B1 (en) 2005-06-30
PT1206462E (pt) 2003-10-31
US6815465B1 (en) 2004-11-09
BG106373A (en) 2002-09-30
CN1243746C (zh) 2006-03-01
CN1372556A (zh) 2002-10-02
NZ517422A (en) 2005-02-25
AU772206B2 (en) 2004-04-22
UA74341C2 (uk) 2005-12-15
SK1822002A3 (en) 2002-08-06
DE60003045D1 (de) 2003-07-03
HUP9902628A3 (en) 2001-07-30
DE60003045T2 (de) 2004-04-01
ES2200900T3 (es) 2004-03-16
CZ2002405A3 (cs) 2002-07-17
IL147904A0 (en) 2002-08-14
HRP20020103A2 (en) 2004-02-29
HK1048995B (zh) 2006-07-21
DK1206462T3 (da) 2003-09-29
AU6309000A (en) 2001-02-19
AP1383A (en) 2005-04-05
EP1206462B1 (de) 2003-05-28
JP2003506366A (ja) 2003-02-18
EP1206462A2 (de) 2002-05-22
CA2378176A1 (en) 2001-02-08
NO20020485L (no) 2002-03-21
AP2002002413A0 (en) 2002-03-31
IS2137B (is) 2006-08-14
OA12004A (en) 2006-04-18
BR0012968A (pt) 2002-05-14

Similar Documents

Publication Publication Date Title
DE60012031D1 (de) Piperazin verbindungen als tachykinin-antagonisten
DE69905582D1 (de) Heterocyclische verbindungen als rotamase-enzymen inhibitoren
ATE299507T1 (de) Bizyklische heteroaromatische verbindungen als lh-agonisten
ATE291575T1 (de) N-carbamoyloxyalkyl-substituierte azolium- verbindungen
ATE299875T1 (de) Benzoamid-piperidin verbindungen als substanz p- antagonisten
ATE437862T1 (de) Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
ATE330954T1 (de) Quinazolin-derivate als vegf-hemmer
DE60032601D1 (de) Als antikrebsmittel verwendbare heterocyklische derivate
DE60003702D1 (de) Heterocyclische verbindungen als reversible inhibitoren von cysteinproteasen
ATE256127T1 (de) Betacarbolinderivate als phosphodiesterase- inhibitoren
ITMI992711A0 (it) Composti organici
ATE286036T1 (de) Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren
DE60106252D1 (de) Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren
DE69910984D1 (de) Heterozyklische verbindungen als inhibitoren der rotamaseaktivität
ATE339403T1 (de) Pyrrolderivate als phosphodiesterase vii-hemmer
DE60008524D1 (de) Furanonderivate als inhibitoren von cathepsin s
ATE236157T1 (de) Imidazopyridinderivate als phosphodiesterase vii- hemmer
IS6413A (is) Setnir 8-arýkínólín fosfódíesterasa-4 latar
ATE245653T1 (de) Imidazolverbindungen als phosphodiesterase vii- hemmer
ATE428420T1 (de) Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer
ATE529419T1 (de) Chromanderivate als estrogene verbindungen
DE60003045D1 (de) Heterozyclische verbindungen als angiogenese inhibitoren
NO20025659L (no) Heterocykliske forbindelser
ATE300945T1 (de) Isoxazolderivate als phosphodiesterase vii-hemmer
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206462

Country of ref document: EP

REN Ceased due to non-payment of the annual fee